COMTESS

This brand name is authorized in Austria, Estonia, Finland, Croatia, Ireland, Lithuania, Netherlands, Poland, Romania, United Kingdom

Active ingredients

The drug COMTESS contains one active pharmaceutical ingredient (API):

1 Entacapone
UNII 4975G9NM6T - ENTACAPONE

Entacapone belongs to a new therapeutic class, catechol-O-methyl transferase (COMT) inhibitors. It is a reversible, specific, and mainly peripherally acting COMT inhibitor designed for concomitant administration with levodopa preparations. Entacapone prolongs the clinical response to levodopa.

Read about Entacapone

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code Group title Classification
N04BX02 Entacapone N Nervous system → N04 Anti-parkinson drugs → N04B Dopaminergic agents → N04BX Other dopaminergic agents
Discover more medicines within N04BX02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
Country: EE Ravimiamet Identifier(s): 1030273, 1064595, 1064607, 1363485
Country: FI Lääkealan turvallisuus- ja kehittämiskeskus Identifier(s): 432229, 433250
Country: GB Medicines & Healthcare Products Regulatory Agency Identifier(s): 22297, 22298
Country: IE Health Products Regulatory Authority Identifier(s): 18221
Country: LT Valstybinė vaistų kontrolės tarnyba Identifier(s): 1002975, 1008049, 1016715, 1028312
Country: NL Z-Index G-Standaard, PRK Identifier(s): 52035
Country: PL Rejestru Produktów Leczniczych Identifier(s): 100160580
Country: RO Agenția Națională a Medicamentului și a Dispozitivelor Medicale Identifier(s): W51543001, W51543002, W51543003, W51543004

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.